Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial (NCT04419480)

🧪 Interventions in This Study

• CardioMEMS implantation with routine ambulatory pulmonary artery pressure monitoring and medication optimization (DEVICE)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• Inova Fairfax Medical Campus — Falls Church, Virginia

📞 Contact the Study Coordinator

Phone: (703) 776-4001

Email: shashank.sinha@inova.org

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Cardiogenic Shock

• A Safety and Efficacy Trial of Istaroxime for Cardiogenic Shock Stage C — Boston, Massachusetts
• Augmented Pacing for Shock in the Cardiac Intensive Care Unit — Nashville, Tennessee
• Can Escalation Reduce Acute Myocardial Infarction Mortality in Cardiogenic Shock — Loma Linda, California
• CORTISHOCK-P: Trial of Corticosteroids in Inflammation-Enriched Heart Failure Cardiogenic Shock — Boston, Massachusetts
• Intra-aortic Balloon Counterpulsation (IABC) Compliance — Philadelphia, Pennsylvania

Explore by condition: All Cardiogenic Shock clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.